We hypothesized that omics investigations of detailed T-cell subsets including CD8+ cytotoxic (TC) and CD4+ helper (TH) T cells at distinct differentiation stages, as defined by CD57 expression, may reveal biological insight and novel targets in MCL. This evidence concerns the gene CD8A and mantle cell lymphoma.